Search

Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DR 1*03 molecules induces antibody production and protection
Authors
Cifuentes, G., Salazar, L., Vargas, L., Parra, C., Vanegas, M., Cortes, J., Patarroyo, M.
Assembly
malaria peptide 1815
Entity
1. malaria peptide 1815 (polymer, Thiol state: not present), 20 monomers, 2442.600 Da Detail

YTNQNINISQ ERDLQKHGFH


Formula weight
2442.6 Da
Exptl. method
solution NMR
Refine. method
distance geometry, DGSA-distance geometry simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 100.0 %, Completeness: 87.1 %, Completeness (bb): 100.0 % Detail

Polymer type: polypeptide(L)

Total1H
All87.1 % (115 of 132)87.1 % (115 of 132)
Backbone100.0 % (41 of 41)100.0 % (41 of 41)
Sidechain81.3 % (74 of 91)81.3 % (74 of 91)
Aromatic61.5 % (8 of 13)61.5 % (8 of 13)
Methyl71.4 % (5 of 7)71.4 % (5 of 7)

1. entity

YTNQNINISQ ERDLQKHGFH

Sample

Solvent system DMSO, Pressure 1 atm, Temperature 295 K, pH 3.7


#NameIsotope labelingTypeConcentration
1DMSOnatural abundance100 %
2Entitynatural abundance0.0 ~ 0.0 mM

Protein Blocks Logo
Calculated from 1 models in PDB: 2MTW, Strand ID: A Detail


Release date
2015-09-30
Citation
Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection
Cifuentes, G., Salazar, L.M., Vargas, L.E., Parra, C.A., Vanegas, M., Cortes, J., Patarroyo, M.E.
Vaccine (2005), 23, 1579-1587, PubMed 15694510 , DOI 10.1016/j.vaccine.2004.08.052 ,
Related entities 1. malaria peptide 1815, : 1 : 2 entities Detail
Experiments performed 3 experiments Detail
NMR combined restraints 4 contents Detail
Keywords EBA-175, NMR, peptide